Beyond Air lands up to $30.1M placement, tied to FDA clearance
What's the deal? Beyond Air has announced a private placement of up to $30.1 million, priced at-the-market under Nasdaq rules. The structure includes $10.2 million upfront, up to $10 million in short-term warrants, and an additional $10 million in long-term warrants.
Why now? The short-term warrants would be accelerated upon FDA clearance, linking a chunk of the financing directly to a regulatory milestone.
The signal: The deal sits in roughly the 91st percentile by size among all-time non-VC private placements in Israel, a sample of 61 rounds — putting Beyond Air near the top of that group and underscoring how medical device firms are structuring capital around clinical and regulatory triggers.
Read more: aktiencheck.de
Image credit: NavyMedicine
